The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for A Christopoulos


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Proof of concept study for designed multiple ligands targeting the dopamine D2, serotonin 5-HT2A, and muscarinic M1 acetylcholine receptors.EBI
Monash University (Parkville Campus)
Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.EBI
Mayo Clinic
Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of thed-opioid receptor.EBI
Bristol-Myers Squibb
Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D2 receptor.EBI
Monash University
Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M1 muscarinic acetylcholine receptor.EBI
Monash University (Parkville Campus)
A structure-activity analysis of biased agonism at the dopamine D2 receptor.EBI
Monash University (Parkville Campus)
Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.EBI
Vanderbilt University Medical Center
Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT2C agonists.EBI
Monash University (Parkville Campus)
Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs.EBI
The Scripps Research Institute
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.EBI
Monash University (Parkville Campus)
2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.EBI
Monash University
Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.EBI
Monash University (Parkville Campus)
Structure-based virtual screening discovers potent and selective adenosine AEBI
Uppsala University
Examining the Role of the Linker in Bitopic EBI
Monash University
The Design, Synthesis, and Evaluation of Novel 9-Arylxanthenedione-Based Allosteric Modulators for the δEBI
Monash University (Parkville Campus)
Novel Irreversible Agonists Acting at the AEBI
Monash University
Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.EBI
Monash University
Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.EBI
Monash University
Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the MEBI
Monash University (Parkville Campus)
A Structure-Activity Relationship Study of Bitopic NEBI
Monash University
Structure-Based Design and Discovery of New MEBI
University of California
2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitorsBDB
4Sc